Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

Nova Biomedical Buys Billerica Flex Building

Feb 13, 2015 | Reprints | Unlock Link | Print

Nova Biomedical Corp. has acquired 165 Lexington Road in Billerica from KS Partners for $1.6 million.

Waltham-based Nova Biomedical develops blood-testing analyzers. It will occupy the entire first floor of the 80,000-square-foot office and flex building. The acquisition complements Nova’s existing Billerica location at 39 Manning Road, an 80,000-square-foot flex building that the company bought in 2011. Nova also has manufacturing facilities in Waltham and Taiwan.

The building was sold through auction.com on behalf of Woburn-based KS Partners. Avison Young’s Jack Kerrigan and Virginia Kerrigan represented Nova in the sale and will market 50,000 square feet of available space on the second floor, along with Colin Whitney of Avison Young’s Boston office.

"After evaluating various market options, Nova determined that the purchase of 165 Lexington Road best aligned with its business objectives of continued growth and investment," Kerrigan said in a statement.

Commercial